APIDRA

Google image searchProduct monograph

Active ingredient

insulin glulisine (recombinant dna origin), 100 UNIT/ML

DIN: 02279460

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 10ML VIAL

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 22-SEP-2008

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AB — Insulins and analogues for injection, fast-acting (ATC, ATC/DDD)
• A10AB06 — INSULIN GLULISINE (ATC/DDD)

Reference brand drug: Apidra

External Links for Apidra

Search on Google

• Apidra side effects
• Apidra dosage
• insulin glulisine side effects
• insulin glulisine dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find apidra photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.